| Date | Form | Description | Docs | XBRL | Pages |
| 09/10/25 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
|
19 |
| 05/28/25 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
|
19 |
| 03/11/25 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
|
17 |
| 09/06/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
19 |
| 06/04/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
31 |
| 03/12/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
17 |
| 09/06/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
19 |
| 06/14/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
19 |
| 03/17/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
17 |
| 09/09/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
21 |
Latest News & Events
Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
Read More...